MIRA insider transaction filings
MIRA PHARMACEUTICALS, INC. — 9 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-15. Screen MIRA transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-15 | 4 | Whalen Matthew Pratt — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Shekhat Denil Nanji — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | MacPherson Edward Clouston — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Del Giudice Matthew Paul — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Aminov Erez — Chief Executive Officer, Director | Grant/award (A): 83,500 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | Shekhat Denil Nanji — Director | Grant/award (A): 22,378 @ $1.35 | EDGAR |
| 2025-10-03 | 4 | Aminov Erez — Chief Executive Officer, Director | Grant/award (A): 2,685,456 | EDGAR |
| 2025-09-18 | 4 | Aminov Erez — Chief Executive Officer, Director | Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | Aminov Erez — Chief Executive Officer, Director | Grant/award (A): 62,500 @ $1.37 | EDGAR |
Recent 8-K events — MIRA PHARMACEUTICALS, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-31 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-07-10 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-06 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-25 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MIRA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →